Katja Pfafferott

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

HIV evolution: CTL escape mutation and reversion after transmission

Alasdair Leslie, Katja Pfafferott, Polan Chetty et al. · Nature Medicine · 2004 · 853 citations

Life Sciences, Infectious Diseases, Molecular Biology +14

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA

Photini Kiepiela, Alasdair Leslie, Isobella Honeyborne et al. · Nature · 2004 · 840 citations

Life Sciences, Genetics, Immunology +14

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie Ewer, Jordan R. Barrett, Sandra Belij‐Rammerstorfer et al. · Nature Medicine · 2020 · 643 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Adaptation of HIV-1 to human leukocyte antigen class I

Yuka Kawashima, Katja Pfafferott, John Frater et al. · Nature · 2009 · 470 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11